The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market From 2026 To 2030?

The market size for bioinformatics in in-vitro diagnostics (ivd) testing has experienced robust growth recently. This market is projected to expand from $98.89 billion in 2025 to $105.59 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. Historically, this expansion has been driven by factors such as increased volumes of molecular diagnostic testing, the growing acceptance of next-generation sequencing in diagnostics, the proliferation of centralized diagnostic laboratories, the presence of sophisticated diagnostic hardware, and the increased application of data-driven clinical decision support systems.

The market for bioinformatics in in-vitro diagnostics (ivd) testing is projected to experience robust expansion in the coming years. This market is forecast to reach $133.49 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.0%. Key factors contributing to this growth during the forecast period include the escalating demand for precision diagnostics, the broadening scope of personalized medicine diagnostics, increasing investments in AI-enabled diagnostic platforms, the expanding utilization of cloud-based diagnostic analytics, and the growing regulatory acceptance of digital diagnostics. Significant trends anticipated in the forecast period encompass the increasing deployment of AI-based diagnostic interpretation software, the rising uptake of cloud-enabled IVD bioinformatics platforms, the growing integration of molecular and clinical data sets, the expansion of companion diagnostics analytics, and an enhanced emphasis on real-time diagnostic data processing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp

What Key Drivers Are Influencing The Growth Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

The rising incidence of cancer is expected to accelerate the growth of bioinformatics in the IVD testing market moving forward. Cancer is a general term for a group of diseases characterized by abnormal cell division that can invade and spread to other areas of the body. The increasing frequency of cancer can be attributed to various elements connected to exposure, lifestyle, and environmental factors. Bioinformatics within IVD testing revolutionizes cancer diagnostics by offering precise, individualized, and comprehensive genetic insights that enhance early detection, inform treatment decisions, and improve patient outcomes. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported a prediction of over 35 million new cancer cases by 2050. Thus, the escalating prevalence of cancer is a key driver for bioinformatics in the IVD testing market.

Which Segments Are Included In The Analysis Of The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

The bioinformatics in in-vitro diagnostics (ivd) testing market covered in this report is segmented –

1) By Component: Hardware, Software

2) By Type Of Test: Blood Based Tests, Tissue Based Tests

3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Other Applications

Subsegments:

1) By Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors And Detectors, Workstations And Data Processing Hardware

2) By Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics And Interpretation Software, Cloud-Based Software Solutions, AI-Based Software For Diagnostics

Which Market Trends Are Creating New Opportunities In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

Leading companies engaged in bioinformatics within the IVD testing market are prioritizing the development of innovative solutions, notably next-generation sequencing (NGS) technology. These efforts aim to enhance the identification and analysis of genetic mutations, improve diagnostic accuracy, and facilitate personalized medicine approaches. Next-generation sequencing (NGS) is recognized as a high-throughput method that enables the rapid sequencing of entire genomes or specific DNA and RNA regions, thereby facilitating comprehensive genetic analysis. For example, in January 2024, QIAGEN Digital Insights, which is the bioinformatics division of the Netherlands-based molecular diagnostics company QIAGEN, released LightSpeed. This ultra-fast NGS secondary-analysis software accelerator is embedded within its CLC Genomics Workbench Premium platform. The LightSpeed module allows laboratories to process somatic cancer NGS data at unprecedented speed, transforming raw sequencing files (FASTQ) into variant calls (VCF) in just minutes, while simultaneously reducing the cost per sample. LightSpeed supports high-throughput cancer panels and is compatible with both cloud-based and on-premises workflows, empowering bioinformatics teams to swiftly analyze multiple tumor genes and biomarkers from a single sample to guide precision oncology decision-making.

Which Key Industry Participants Are Active In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

Major companies operating in the bioinformatics in in-vitro diagnostics (ivd) testing market are Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio-Rad Laboratories Inc, Eurofins Scientific SE

Read the full bioinformatics in in-vitro diagnostics (ivd) testing market report here:

https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market?

North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (ivd) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16629&type=smp

Browse Through More Reports Similar to the Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market 2026, By The Business Research Company

Bioinformatics Services Global Market Report

https://www.thebusinessresearchcompany.com/report/bioinformatics-services-global-market-report

Ai In Bioinformatics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report

Chemoinformatics Global Market Report

https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model